{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:56:54Z","timestamp":1793642214236,"version":"4.5.1"},"publisher-location":"Cham","reference-count":74,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031598142","type":"print"},{"value":"9783031598159","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_38","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-Interferon-\u03b3 Therapy for Cytokine Storm Syndromes"],"prefix":"10.1007","author":[{"given":"Edward M.","family":"Behrens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"de Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"9","key":"38_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFNgamma: Signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545\u201358. https:\/\/doi.org\/10.1038\/s41577-018-0029-z.","journal-title":"Nat Rev Immunol"},{"key":"38_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41\u2013101. https:\/\/doi.org\/10.1016\/S0065-2776(07)96002-2.","journal-title":"Adv Immunol"},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fimmu.2013.00267","volume":"4","author":"CM Blouin","year":"2013","unstructured":"Blouin CM, Lamaze C. Interferon gamma receptor: The beginning of the journey. Front Immunol. 2013;4:267. https:\/\/doi.org\/10.3389\/fimmu.2013.00267.","journal-title":"Front Immunol"},{"issue":"5","key":"38_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/icb.2012.9","volume":"90","author":"NA de Weerd","year":"2012","unstructured":"de Weerd NA, Nguyen T. The interferons and their receptors\u2013distribution and regulation. Immunol Cell Biol. 2012;90(5):483\u201391. https:\/\/doi.org\/10.1038\/icb.2012.9.","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"38_CR5","doi-asserted-by":"publisher","first-page":"e01978","DOI":"10.1128\/mBio.01978-14","volume":"5","author":"JE Suarez-Ramirez","year":"2014","unstructured":"Suarez-Ramirez JE, Tarrio ML, Kim K, Demers DA, Biron CA. CD8 T cells in innate immune responses: Using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection. MBio. 2014;5(5):e01978\u201314. https:\/\/doi.org\/10.1128\/mBio.01978-14.","journal-title":"MBio"},{"issue":"10","key":"38_CR6","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1182\/blood-2010-07-294702","volume":"117","author":"Y Kannan","year":"2011","unstructured":"Kannan Y, Yu J, Raices RM, Seshadri S, Wei M, Caligiuri MA, et al. IkappaBzeta augments IL-12- and IL-18-mediated IFN-gamma production in human NK cells. Blood. 2011;117(10):2855\u201363. https:\/\/doi.org\/10.1182\/blood-2010-07-294702.","journal-title":"Blood"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","volume":"8","author":"A Majoros","year":"2017","unstructured":"Majoros A, Platanitis E, Kernbauer-Holzl E, Rosebrock F, Muller M, Decker T. Canonical and non-canonical aspects of JAK-STAT signaling: Lessons from interferons for cytokine responses. Front Immunol. 2017;8:29. https:\/\/doi.org\/10.3389\/fimmu.2017.00029.","journal-title":"Front Immunol"},{"issue":"1","key":"38_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3892\/ijmm.2016.2583","volume":"38","author":"C Xie","year":"2016","unstructured":"Xie C, Liu C, Wu B, Lin Y, Ma T, Xiong H, et al. Effects of IRF1 and IFN-beta interaction on the M1 polarization of macrophages and its antitumor function. Int J Mol Med. 2016;38(1):148\u201360. https:\/\/doi.org\/10.3892\/ijmm.2016.2583.","journal-title":"Int J Mol Med"},{"issue":"1","key":"38_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.imbio.2017.10.005","volume":"223","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. Immunobiology. 2018;223(1):101\u201311. https:\/\/doi.org\/10.1016\/j.imbio.2017.10.005.","journal-title":"Immunobiology"},{"issue":"3","key":"38_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest. 2012;122(3):787\u201395. https:\/\/doi.org\/10.1172\/JCI59643.","journal-title":"J Clin Invest"},{"issue":"7","key":"38_CR11","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1128\/iai.61.7.2872-2878.1993","volume":"61","author":"M Asano","year":"1993","unstructured":"Asano M, Nakane A, Minagawa T. Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice. Infect Immun. 1993;61(7):2872\u20138.","journal-title":"Infect Immun"},{"issue":"34","key":"38_CR12","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1074\/jbc.R116.774745","volume":"292","author":"DS Green","year":"2017","unstructured":"Green DS, Young HA, Valencia JC. Current prospects of type II interferon gamma signaling and autoimmunity. J Biol Chem. 2017;292(34):13925\u201333. https:\/\/doi.org\/10.1074\/jbc.R116.774745.","journal-title":"J Biol Chem"},{"issue":"1","key":"38_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/cimm.2001.1819","volume":"211","author":"JE Pearl","year":"2001","unstructured":"Pearl JE, Saunders B, Ehlers S, Orme IM, Cooper AM. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. Cell Immunol. 2001;211(1):43\u201350. https:\/\/doi.org\/10.1006\/cimm.2001.1819.","journal-title":"Cell Immunol"},{"issue":"3","key":"38_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/imm.12524","volume":"146","author":"EJ Swindle","year":"2015","unstructured":"Swindle EJ, Brown JM, Radinger M, DeLeo FR, Metcalfe DD. Interferon-gamma enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus. Immunology. 2015;146(3):470\u201385. https:\/\/doi.org\/10.1111\/imm.12524.","journal-title":"Immunology"},{"issue":"6","key":"38_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","volume":"24","author":"J Choi","year":"2012","unstructured":"Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 2012;24(6):651\u20137. https:\/\/doi.org\/10.1016\/j.coi.2012.10.004.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"38_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163\u201389. https:\/\/doi.org\/10.1189\/jlb.0603252.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"38_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cimid.2007.07.014","volume":"31","author":"I Fidan","year":"2008","unstructured":"Fidan I, Yesilyurt E, Gurelik FC, Erdal B, Imir T. Effects of recombinant interferon-gamma on cytokine secretion from monocyte-derived macrophages infected with Salmonella typhi. Comp Immunol Microbiol Infect Dis. 2008;31(6):467\u201375. https:\/\/doi.org\/10.1016\/j.cimid.2007.07.014.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"3","key":"38_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1046\/j.1365-2567.2000.00955.x","volume":"99","author":"S Bao","year":"2000","unstructured":"Bao S, Beagley KW, France MP, Shen J, Husband AJ. Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology. 2000;99(3):464\u201372.","journal-title":"Immunology"},{"issue":"5","key":"38_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/655472","volume":"202","author":"PJ van de Berg","year":"2010","unstructured":"van de Berg PJ, Heutinck KM, Raabe R, Minnee RC, Young SL, van Donselaar-van der Pant KA, et al. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis. 2010;202(5):690\u20139. https:\/\/doi.org\/10.1086\/655472.","journal-title":"J Infect Dis"},{"key":"38_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1743-422X-2-14","volume":"2","author":"B Sainz Jr","year":"2005","unstructured":"Sainz B Jr, LaMarca HL, Garry RF, Morris CA. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha\/beta and interferon-gamma. Virol J. 2005;2:14. https:\/\/doi.org\/10.1186\/1743-422X-2-14.","journal-title":"Virol J"},{"issue":"7","key":"38_CR21","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.4049\/jimmunol.1501035","volume":"196","author":"E Brisse","year":"2016","unstructured":"Brisse E, Imbrechts M, Put K, Avau A, Mitera T, Berghmans N, et al. Mouse cytomegalovirus infection in BALB\/c mice resembles virus-associated secondary Hemophagocytic Lymphohistiocytosis and shows a pathogenesis distinct from primary Hemophagocytic Lymphohistiocytosis. J Immunol. 2016;196(7):3124\u201334. https:\/\/doi.org\/10.4049\/jimmunol.1501035.","journal-title":"J Immunol"},{"issue":"6","key":"38_CR22","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to mycobacterium tuberculosis infection. J Exp Med. 1993;178(6):2249\u201354.","journal-title":"J Exp Med"},{"issue":"4","key":"38_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.14411\/fp.2004.033","volume":"51","author":"J Salat","year":"2004","unstructured":"Salat J, Sak B, Le T, Kopecky J. Susceptibility of IFN-gamma or IL-12 knock-out and SCID mice to infection with two microsporidian species, Encephalitozoon cuniculi and E. intestinalis. Folia Parasitol. 2004;51(4):275\u201382.","journal-title":"Folia Parasitol"},{"issue":"5","key":"38_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0022-3476(99)70064-8","volume":"135","author":"SE Dorman","year":"1999","unstructured":"Dorman SE, Uzel G, Roesler J, Bradley JS, Bastian J, Billman G, et al. Viral infections in interferon-gamma receptor deficiency. J Pediatr. 1999;135(5):640\u20133.","journal-title":"J Pediatr"},{"issue":"1","key":"38_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1203\/00006450-200107000-00005","volume":"50","author":"N Remus","year":"2001","unstructured":"Remus N, Reichenbach J, Picard C, Rietschel C, Wood P, Lammas D, et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res. 2001;50(1):8\u201313. https:\/\/doi.org\/10.1203\/00006450-200107000-00005.","journal-title":"Pediatr Res"},{"issue":"5","key":"38_CR26","first-page":"418","volume":"26","author":"DQ Tran","year":"2005","unstructured":"Tran DQ. Susceptibility to mycobacterial infections due to interferon-gamma and interleukin-12 pathway defects. Allergy Asthma Proc. 2005;26(5):418\u201321.","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"38_CR27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/hmg\/ddr029","volume":"20","author":"I Sologuren","year":"2011","unstructured":"Sologuren I, Boisson-Dupuis S, Pestano J, Vincent QB, Fernandez-Perez L, Chapgier A, et al. Partial recessive IFN-gammaR1 deficiency: Genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet. 2011;20(8):1509\u201323. https:\/\/doi.org\/10.1093\/hmg\/ddr029.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"38_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1046\/j.1365-2249.2000.01284.x","volume":"121","author":"DA Lammas","year":"2000","unstructured":"Lammas DA, Casanova JL, Kumararatne DS. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol. 2000;121(3):417\u201325.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"38_CR29","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI19316","volume":"115","author":"B Kampmann","year":"2005","unstructured":"Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115(9):2480\u20138. https:\/\/doi.org\/10.1172\/JCI19316.","journal-title":"J Clin Invest"},{"issue":"9","key":"38_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076371","volume":"8","author":"P Wongkulab","year":"2013","unstructured":"Wongkulab P, Wipasa J, Chaiwarith R, Supparatpinyo K. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in northern Thailand. PLoS One. 2013;8(9):e76371. https:\/\/doi.org\/10.1371\/journal.pone.0076371.","journal-title":"PLoS One"},{"issue":"6","key":"38_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269553","volume":"17","author":"T Diamond","year":"2022","unstructured":"Diamond T, Burn TN, Nishiguchi MA, Minichino D, Chase J, Chu N, et al. Familial hemophagocytic lymphohistiocytosis hepatitis is mediated by IFN-gamma in a predominantly hepatic-intrinsic manner. PLoS One. 2022;17(6):e0269553. https:\/\/doi.org\/10.1371\/journal.pone.0269553.","journal-title":"PLoS One"},{"issue":"1","key":"38_CR32","doi-asserted-by":"publisher","first-page":"12298","DOI":"10.1038\/s41598-023-39601-9","volume":"13","author":"T Diamond","year":"2023","unstructured":"Diamond T, Lau M, Morrissette J, Chu N, Behrens EM. CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis. Sci Rep. 2023;13(1):12298. https:\/\/doi.org\/10.1038\/s41598-023-39601-9.","journal-title":"Sci Rep"},{"issue":"6","key":"38_CR33","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20102538","volume":"208","author":"EE Zoller","year":"2011","unstructured":"Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med. 2011;208(6):1203\u201314. https:\/\/doi.org\/10.1084\/jem.20102538.","journal-title":"J Exp Med"},{"issue":"6","key":"38_CR34","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011;121(6):2264\u201377. https:\/\/doi.org\/10.1172\/JCI43157.","journal-title":"J Clin Invest"},{"issue":"4","key":"38_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.20062447","volume":"204","author":"K Crozat","year":"2007","unstructured":"Crozat K, Hoebe K, Ugolini S, Hong NA, Janssen E, Rutschmann S, et al. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: A mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med. 2007;204(4):853\u201363. https:\/\/doi.org\/10.1084\/jem.20062447.","journal-title":"J Exp Med"},{"issue":"13","key":"38_CR36","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1073\/pnas.131193098","volume":"98","author":"MJ Czar","year":"2001","unstructured":"Czar MJ, Kersh EN, Mijares LA, Lanier G, Lewis J, Yap G, et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/SAP. Proc Natl Acad Sci USA. 2001;98(13):7449\u201354. https:\/\/doi.org\/10.1073\/pnas.131193098.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"38_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1182\/blood-2012-07-441139","volume":"121","author":"T Kogl","year":"2013","unstructured":"Kogl T, Muller J, Jessen B, Schmitt-Graeff A, Janka G, Ehl S, et al. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood. 2013;121(4):604\u201313. https:\/\/doi.org\/10.1182\/blood-2012-07-441139.","journal-title":"Blood"},{"issue":"2","key":"38_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/emmm.200900009","volume":"1","author":"J Pachlopnik Schmid","year":"2009","unstructured":"Pachlopnik Schmid J, Ho CH, Chretien F, Lefebvre JM, Pivert G, Kosco-Vilbois M, et al. Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med. 2009;1(2):112\u201324. https:\/\/doi.org\/10.1002\/emmm.200900009.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"38_CR39","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jaci.2017.07.021","volume":"141","author":"G Prencipe","year":"2018","unstructured":"Prencipe G, Caiello I, Pascarella A, Grom AA, Bracaglia C, Chatel L, et al. Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome. J Allergy Clin Immunol. 2018;141(4):1439\u201349. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.021.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"38_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","volume":"104","author":"MB Jordan","year":"2004","unstructured":"Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104(3):735\u201343. https:\/\/doi.org\/10.1182\/blood-2003-10-3413.","journal-title":"Blood"},{"issue":"3","key":"38_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, Andrews DM, et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307\u201317. https:\/\/doi.org\/10.1084\/jem.20140964.","journal-title":"J Exp Med"},{"issue":"6","key":"38_CR42","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","volume":"196","author":"M Zhang","year":"2016","unstructured":"Zhang M, Bracaglia C, Prencipe G, Bemrich-Stolz CJ, Beukelman T, Dimmitt RA, et al. A heterozygous RAB27A mutation associated with delayed Cytolytic granule polarization and Hemophagocytic Lymphohistiocytosis. J Immunol. 2016;196(6):2492\u2013503. https:\/\/doi.org\/10.4049\/jimmunol.1501284.","journal-title":"J Immunol"},{"key":"38_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.trsl.2016.07.023","volume":"180","author":"V Buatois","year":"2017","unstructured":"Buatois V, Chatel L, Cons L, Lory S, Richard F, Guilhot F, et al. Use of a mouse model to identify a blood biomarker for IFNgamma activity in pediatric secondary hemophagocytic lymphohistiocytosis. Transl Res. 2017;180:37\u201352 e2. https:\/\/doi.org\/10.1016\/j.trsl.2016.07.023.","journal-title":"Transl Res"},{"issue":"9","key":"38_CR44","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/art.1780340912","volume":"34","author":"F de Benedetti","year":"1991","unstructured":"de Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1991;34(9):1158\u201363.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"38_CR45","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/art.33496","volume":"64","author":"R Strippoli","year":"2012","unstructured":"Strippoli R, Carvello F, Scianaro R, De Pasquale L, Vivarelli M, Petrini S, et al. Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: Implication for the pathogenesis of macrophage activation syndrome. Arthritis Rheum. 2012;64(5):1680\u20138. https:\/\/doi.org\/10.1002\/art.33496.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"38_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood-2018-05-850321","volume":"133","author":"S Humblet-Baron","year":"2019","unstructured":"Humblet-Baron S, Barber JS, Roca CP, Lenaerts A, Koni PA, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2019;133(4):319\u201330. https:\/\/doi.org\/10.1182\/blood-2018-05-850321.","journal-title":"Blood"},{"issue":"1","key":"38_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/art.40683","volume":"71","author":"LK Weaver","year":"2019","unstructured":"Weaver LK, Chu N, Behrens EM. Brief report: Interferon-gamma-mediated immunopathology potentiated by toll-like receptor 9 activation in a murine model of macrophage activation syndrome. Arthritis Rhematol. 2019;71(1):161\u20138. https:\/\/doi.org\/10.1002\/art.40683.","journal-title":"Arthritis Rhematol"},{"issue":"11","key":"38_CR48","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","volume":"78","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78(11):2918\u201322.","journal-title":"Blood"},{"issue":"3","key":"38_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00043426-199805000-00005","volume":"20","author":"S Imashuku","year":"1998","unstructured":"Imashuku S, Hibi S, Sako M, Ishii T, Kohdera U, Kitazawa K, et al. Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: Comparative study of 9 familial and 14 familial inheritance-unproved cases. J Pediatr Hematol Oncol. 1998;20(3):207\u201314.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"38_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<131::AID-MPO1>3.0.CO;2-C","volume":"31","author":"S Imashuku","year":"1998","unstructured":"Imashuku S, Hibi S, Tabata Y, Sako M, Sekine Y, Hirayama K, et al. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 1998;31(3):131\u20137.","journal-title":"Med Pediatr Oncol"},{"issue":"8","key":"38_CR51","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","volume":"54","author":"K Put","year":"2015","unstructured":"Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, et al. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: Tipping the balance between interleukin-18 and interferon-gamma. Rheumatology (Oxford, England). 2015;54(8):1507\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/keu524.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"8","key":"38_CR52","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2001-12-0260","volume":"100","author":"EM Schneider","year":"2002","unstructured":"Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood. 2002;100(8):2891\u20138. https:\/\/doi.org\/10.1182\/blood-2001-12-0260.","journal-title":"Blood"},{"issue":"6","key":"38_CR53","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","volume":"160","author":"XJ Xu","year":"2012","unstructured":"Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Zhao N, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160(6):984\u201390 e1. https:\/\/doi.org\/10.1016\/j.jpeds.2011.11.046.","journal-title":"J Pediatr"},{"key":"38_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2016.05.022","volume":"85","author":"SL Yang","year":"2016","unstructured":"Yang SL, Xu XJ, Tang YM, Song H, Xu WQ, Zhao FY, et al. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis. Cytokine. 2016;85:14\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2016.05.022.","journal-title":"Cytokine"},{"issue":"1","key":"38_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76(1):166\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209020.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"38_CR56","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2385\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1112802.","journal-title":"N Engl J Med"},{"issue":"25","key":"38_CR57","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2396\u2013406. https:\/\/doi.org\/10.1056\/NEJMoa1205099.","journal-title":"N Engl J Med"},{"issue":"9","key":"38_CR58","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford, England). 2010;49(9):1645\u201353. https:\/\/doi.org\/10.1093\/rheumatology\/keq133.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"13","key":"38_CR59","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarc\u2019h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131(13):1442\u201355. https:\/\/doi.org\/10.1182\/blood-2017-12-820852.","journal-title":"Blood"},{"key":"38_CR60","first-page":"964","volume-title":"Congress of the International Society of Systemic Autoinflammatory Diseases","author":"MT Lam","year":"2019","unstructured":"Lam MT, Coppola S, Krumbach OH, Prencipe G, Insalaco A, Cifaldi C. A novel autoinflammatory disease characterized by neonatal-onset cytopenia with autoinflammation, rash, and hemophagocytosis (NOCARH) due to aberrant CDC42 function. In: Congress of the International Society of Systemic Autoinflammatory Diseases, vol. 78; 2019. p. 964."},{"issue":"1","key":"38_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","volume":"65","author":"T Wada","year":"2014","unstructured":"Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65(1):74\u20138. https:\/\/doi.org\/10.1016\/j.cyto.2013.09.007.","journal-title":"Cytokine"},{"issue":"13","key":"38_CR62","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","volume":"131","author":"C Girard-Guyonvarc\u2019h","year":"2018","unstructured":"Girard-Guyonvarc\u2019h C, Palomo J, Martin P, Rodriguez E, Troccaz S, Palmer G, et al. Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice. Blood. 2018;131(13):1430\u201341. https:\/\/doi.org\/10.1182\/blood-2017-06-789552.","journal-title":"Blood"},{"issue":"27","key":"38_CR63","doi-asserted-by":"publisher","first-page":"16139","DOI":"10.1074\/jbc.271.27.16139","volume":"271","author":"H Lortat-Jacob","year":"1996","unstructured":"Lortat-Jacob H, Baltzer F, Grimaud JA. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence. J Biol Chem. 1996;271(27):16139\u201343.","journal-title":"J Biol Chem"},{"issue":"7","key":"38_CR64","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1006\/cyto.1996.0075","volume":"8","author":"H Lortat-Jacob","year":"1996","unstructured":"Lortat-Jacob H, Brisson C, Guerret S, Morel G. Non-receptor-mediated tissue localization of human interferon-gamma: Role of heparan sulfate\/heparin-like molecules. Cytokine. 1996;8(7):557\u201366. https:\/\/doi.org\/10.1006\/cyto.1996.0075.","journal-title":"Cytokine"},{"issue":"3","key":"38_CR65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","volume":"133","author":"H Takada","year":"2003","unstructured":"Takada H, Takahata Y, Nomura A, Ohga S, Mizuno Y, Hara T. Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis. Clin Exp Immunol. 2003;133(3):448\u201353.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"38_CR66","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2141.2009.07957.x","volume":"148","author":"LT My","year":"2010","unstructured":"My LT, Lien le B, Hsieh WC, Imamura T, Anh TN, Anh PN, et al. Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children. Br J Haematol. 2010;148(2):301\u201310. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07957.x.","journal-title":"Br J Haematol"},{"key":"38_CR67","doi-asserted-by":"publisher","first-page":"46652","DOI":"10.1038\/srep46652","volume":"7","author":"JH Han","year":"2017","unstructured":"Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, et al. Elevated circulating levels of the interferon-gamma-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still\u2019s disease. Sci Rep. 2017;7:46652. https:\/\/doi.org\/10.1038\/srep46652.","journal-title":"Sci Rep"},{"issue":"4","key":"38_CR68","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: Characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood. 2005;105(4):1648\u201351. https:\/\/doi.org\/10.1182\/blood-2004-08-2997.","journal-title":"Blood"},{"key":"38_CR69","first-page":"LBA-6","volume":"132","author":"FJ Locatelli","year":"2018","unstructured":"Locatelli FJ, Jordan MB, Alllen CE. Safety and efficacy of Emapalumab in pediatric patients with primary Hemophagocytic Lymphohistiocytosis. Am Soc Hematol Annu Meet. 2018;132:LBA-6.","journal-title":"Am Soc Hematol Annu Meet"},{"issue":"1","key":"38_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","volume":"3","author":"DT Lounder","year":"2019","unstructured":"Lounder DT, Bin Q, de Min C, Jordan MB. Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections. Blood Adv. 2019;3(1):47\u201350. https:\/\/doi.org\/10.1182\/bloodadvances.2018025858.","journal-title":"Blood Adv"},{"issue":"suppl 2","key":"38_CR71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12969-018-0265-6","volume":"16","author":"C Bracaglia","year":"2018","unstructured":"Bracaglia C. Emapalumab, an anti-interferon gamma monoclonal antibody in two patients with NLRC4-related disease and severe Hemophagocytic Lymphohistiocytosis (HLH). Pediatr Rheumatol. 2018;16(suppl 2):2. https:\/\/doi.org\/10.1186\/s12969-018-0265-6.","journal-title":"Pediatr Rheumatol"},{"issue":"6","key":"38_CR72","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/ard-2022-223739","volume":"82","author":"F De Benedetti","year":"2023","unstructured":"De Benedetti F, Grom AA, Brogan PA, Bracaglia C, Pardeo M, Marucci G, et al. Efficacy and safety of emapalumab in macrophage activation syndrome. Ann Rheum Dis. 2023;82(6):857\u201365. https:\/\/doi.org\/10.1136\/ard-2022-223739.","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"38_CR73","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1182\/bloodadvances.2023010712","volume":"7","author":"MR Schuelke","year":"2023","unstructured":"Schuelke MR, Bassiri H, Behrens EM, Canna S, Croy C, DiNofia A, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603\u20137. https:\/\/doi.org\/10.1182\/bloodadvances.2023010712.","journal-title":"Blood Adv"},{"issue":"1","key":"38_CR74","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13256-023-03808-1","volume":"17","author":"A AlAhmari","year":"2023","unstructured":"AlAhmari A, Khogeer H. Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Ch\u00e9diak-Higashi syndrome: A case report. J Med Case Rep. 2023;17(1):113. https:\/\/doi.org\/10.1186\/s13256-023-03808-1.","journal-title":"J Med Case Rep"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:07:49Z","timestamp":1723154869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_38","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}